Using a selective CD73 small-molecule inhibitor, we showed that inhibition of CD73 increased ADP-induced αIIbβ3 expression in platelets from CLL patients (Figure 3). The gene discussed is NT5E; the disease is B-cell chronic lymphocytic leukemia.